ARTICLE | Top Story
Titan reports Phase III data
September 25, 2000 7:00 AM UTC
TTP said data from a 600-patient, international Phase III trial showed both dose levels of its Zomaril iloperidone achieved a statistically significant reduction in the symptoms of schizophrenia as as...